Posted by Michael Wonder on 15 Jun 2022
Calls for 'blockbuster' osteoporosis drug to be made widely available
14 June 2022 - Experts want to see a new "blockbuster" drug made accessible for more patients suffering from osteoporosis.
The treatment, Evenity (romosozumab), was subsidised on the Pharmaceutical Benefits Scheme last year.
However, it has a strict access scheme and is limited to patients who've had two or more fractures and who are deemed high risk on their bone mineral density scan.
